The impact of peri-procedural imaging on safety and efficacy of atrial fibrillation ablation: insights from the Israeli AF Catheter Ablation Registry (ICAR)

被引:0
|
作者
Marai, Ibrahim [1 ]
Elias, Adi [2 ,3 ]
Rozen, Guy [1 ]
Beinart, Roy [4 ,5 ]
Nof, Eyal [4 ,5 ]
Michowitz, Yoav [6 ,7 ]
Glikson, Michael [6 ,7 ]
Konstantino, Yuval [8 ]
Haim, Moti [8 ]
Luria, David [9 ,10 ]
Omelchenko, Alexander [5 ,11 ]
Laish-Farkash, Avishag [12 ]
Suleiman, Mahmoud [2 ,3 ]
机构
[1] PoriyaBar Ilan Univ, Azrieli Fac Med,Cardiovasc Dept, Lydia & Carol Kittner Poriya Med Ctr, Lea & Benjamin Davidai Div Cardiovasc Med & Surg, Lower Galilee, Tiberias, Israel
[2] Eyal Ofer Heart Hosp, Technion, Cardiac Electrophysiol & Pacing, Rambam Hlth Care Campus, Haifa, Israel
[3] Eyal Ofer Heart Hosp, Technion, B Rappaport Fac Med, Cardiac Electrophysiol & Pacing, Haifa, Israel
[4] Sheba Med Ctr, Heart Inst, Tel Hashomer, Israel
[5] Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel
[6] Shaare Zedek Med Ctr, Jesselson Integrated Heart Ctr, Jerusalem, Israel
[7] Hebrew Univ Jerusalem, Jerusalem, Israel
[8] Ben Gurion Univ Negev, Soroka Univ Hosp, Dept Cardiol Cardiac Electrophysiol & Pacing, Beer Sheva, Israel
[9] Hebrew Univ Jerusalem, Dept Cardiol, Hadassah Med Org, Jerusalem, Israel
[10] Hebrew Univ Jerusalem, Fac Med, Jerusalem, Israel
[11] Meir Med Ctr, Cardiol Dept, Kefar Sava, Israel
[12] Ben Gurion Univ Negev, Assuta Ashdod Univ Med Ctr, Dept Cardiol Electrophysiol, Pacing Unit, Beer Sheva, Israel
关键词
Atrial fibrillation; Ablation; Imaging; Pulmonary vein isolation; RADIOFREQUENCY; OUTCOMES;
D O I
10.1007/s10840-024-01887-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundPulmonary vein isolation (PVI) is the most effective therapy to achieve rhythm control in atrial fibrillation (AF). Peri-procedural imaging is used in many but not all centers. However, the impact of imaging on safety and efficacy of PVI is not clear. The Israeli Catheter Ablation Registry (ICAR) is a great opportunity to explore this issue in real-world practice.AimTo describe the real-world utilization of peri-procedural imaging technologies in a large cohort of patients undergoing ablation for AF.MethodsA prospective-multicenter cohort of AF patients who underwent PVI during the years 2019-2021. Peri-procedural imaging (CT, ICE, TEE) was utilized based on the center and operator discretion. The study endpoints were peri-procedural complications and AF recurrence at 12 months follow-up among patients with and without peri-procedural imaging.ResultsBetween January 2019 and December 2021, a total of 921 patients underwent PVI. Peri-procedural imaging (at least 1 modality of CT, TEE, and or ICE) was utilized in 753 (81.8%) and no imaging among 168 (18.2%) patients. Cryoablation was the dominant energy used for PVI in both groups (92.3% of the non-imaging group, and 95.3% among imaging group), while RF was used in the rest of the patients. Fluoroscopy time was not different between the 2 groups; however, procedure duration was longer among the imaging group (90 min) compared to the non-imaging group (74.5 min, p = 0.006). By 12 months, the incidence of AF recurrence and repeated ablation were not different between the groups. Complications and re-hospitalization for cardiocerebrovascular reasons were not different among the 2 groups. Cox regression model demonstrated no association between preprocedural imaging and the risk of AF recurrence after ablation.ConclusionThis real-world multicenter prospective registry study demonstrated that the rate of complications and the rate of recurrence of AF during 1 year follow-up were not different among patients who had PVI either with or without peri-procedural imaging.
引用
收藏
页码:73 / 81
页数:9
相关论文
共 50 条
  • [41] Efficacy and Safety of Catheter Ablation for Persistent or Permanent Atrial Fibrillation
    Muraoka, Soichi
    Mitsutake, Chiharu
    Takashima, Hideo
    Nakashima, Hideko
    Yasuda, Tomoo
    Matsumoto, Naomichi
    Kumagai, Koichiro
    Saku, Keijiro
    JOURNAL OF ARRHYTHMIA, 2007, 23 (03) : 229 - 235
  • [42] Safety and efficacy of catheter ablation for atrial fibrillation in the very elderly
    Wahedi, R.
    Willems, S.
    Jularic, M.
    Hartmann, J.
    Schaeffer, B.
    Akbulak-Stegli, O.
    Eickholt, C.
    Anwar, O.
    Maurer, T.
    Hedenus, K.
    Gunawardene, M.
    EUROPEAN HEART JOURNAL, 2022, 43 : 459 - 459
  • [43] Efficacy and safety of catheter ablation for atrial fibrillation in patients with cancer
    Ganatra, S.
    Abraham, S.
    Parikh, R.
    Kamenetsky, D.
    Patel, R.
    Dani, S.
    Chaudhry, G.
    Resnic, F.
    Shah, S.
    Venesy, D.
    Patten, R.
    Neilan, T.
    Reynolds, M.
    Hook, B.
    Nohria, A.
    EUROPEAN HEART JOURNAL, 2020, 41 : 3278 - 3278
  • [44] Efficacy, safety and outcome of catheter ablation for atrial fibrillation in octogenarians
    Tan, Hong-wei
    Wang, Xin-hua
    Shi, Hai-feng
    Yang, Guo-shu
    Zhou, Li
    Gu, Jia-ning
    Jiang, Wei-feng
    Liu, Xu
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2010, 145 (01) : 147 - 148
  • [45] Antiarrhythmic drug therapy after catheter ablation for atrial fibrillation-Insights from the German Ablation Registry
    Schleberger, Ruben
    Metzner, Andreas
    Kuck, Karl-Heinz
    Andresen, Dietrich
    Willems, Stephan
    Hoffmann, Ellen
    Deneke, Thomas
    Eckardt, Lars
    Brachmann, Johannes
    Hochadel, Matthias
    Senges, Jochen
    Rillig, Andreas
    PHARMACOLOGY RESEARCH & PERSPECTIVES, 2021, 9 (06):
  • [46] Catheter ablation of atrial fibrillation in patients with concomitant sinus bradycardia-Insights from the German Ablation Registry
    Zylla, Maura M.
    Brachmann, Johannes
    Lewalter, Thorsten
    Hoffmann, Ellen
    Kuck, Karl-Heinz
    Andresen, Dietrich
    Willems, Stephan
    Hochadel, Matthias
    Senges, Jochen
    Katus, Hugo A.
    Thomas, Dierk
    JOURNAL OF ELECTROCARDIOLOGY, 2016, 49 (02) : 117 - 123
  • [47] Peri-procedural anticoagulation in patients with end-stage kidney disease undergoing atrial fibrillation ablation: results from the multicentre end-stage kidney disease-atrial fibrillation ablation registry
    Yamamoto, Tasuku
    Miyazaki, Shinsuke
    Tanaka, Yasuaki
    Kono, Toshikazu
    Nakata, Tadanori
    Mizukami, Akira
    Aoyama, Daisetsu
    Arai, Hirofumi
    Taomoto, Yuta
    Horie, Tomoki
    Hojo, Rintaro
    Kawamoto, Shiho
    Yabe, Kento
    Akiyoshi, Kikou
    Kato, Nobutaka
    Ono, Yuichi
    Suzuki, Atsushi
    Fukamizu, Seiji
    Nagata, Yasutoshi
    Yamauchi, Yasuteru
    Tada, Hiroshi
    Hachiya, Hitoshi
    Inaba, Osamu
    Takahashi, Atsushi
    Goya, Masahiko
    Sasano, Tetsuo
    EUROPACE, 2023, 25 (04): : 1400 - 1407
  • [48] Left atrium ablation for atrial fibrillation: a multicenter perspective registry on procedural safety
    Bertaglia, E.
    Zoppo, F.
    Colella, A.
    Bottoni, N.
    Stabile, G.
    Zerbo, F.
    D'este, D.
    Pascotto, P.
    EUROPEAN HEART JOURNAL, 2006, 27 : 870 - 870
  • [49] Peri-procedural interrupted oral anticoagulation for atrial fibrillation ablation: comparison of aspirin, warfarin, dabigatran, and rivaroxaban
    Winkle, Roger A.
    Mead, R. Hardwin
    Engel, Gregory
    Kong, Melissa H.
    Patrawala, Rob A.
    EUROPACE, 2014, 16 (10): : 1443 - 1449
  • [50] Uninterrupted Novel Oral Anticoagulants and Warfarin Use for Peri-procedural Anticoagulation during Atrial Fibrillation Ablation
    Kanmanthareddy, Arun K.
    Buddam, Avanija R.
    Reddy, Madhu
    Alla, Venkata M.
    Hunter, Claire
    Lakkireddy, Dhanunjaya
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (15) : B82 - B83